【结 构 式】 |
【分子编号】12956 【品名】bis(2,4,6-trichlorophenyl) malonate 【CA登记号】 |
【 分 子 式 】C15H6Cl6O4 【 分 子 量 】462.92644 【元素组成】C 38.92% H 1.31% Cl 45.95% O 13.82% |
合成路线1
该中间体在本合成路线中的序号:(IV)This compound can be obtained by two related ways: 1) The cyclization of 3-cyclohexylpropionitrile (I) with thiosemicarbazide (II) by means of trifluoroacetic acid gives 5-(2-cyclohexylethyl)-1,3,4-thiadiazol-2-amino (III), which is submitted to a new cyclization process with bis(2,4,6-trichlorophenyl)malonate (IV) in refluxing xylene yielding 2-(2-cyclohexylethyl)-7-hydroxy-5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one (V) (1-3). The nitration of (V) with fuming nitric acid in acetic acid affords the corresponding 7-hydroxy-6-nitro derivative (VI), which is treated with POCl3 and tripropylamine to afford the 7-chloro-6-nitro derivative (VII). The reaction of (VII) with concentrated aqueous NH4OH in ethanol gives the corresponding 7-amino-6-nitro compound (VIII), which is reduced with Sn-HCl in dioxane-water to afford the 6,7-diamino derivative (IX). Finally, this compound is dissolved in aqueous HCl and treated with NaNO2. 2) The cyclization of 3-cyclohexylpropionic acid (X) with thiosemicarbazide (II) by means of hot H2SO4 gives the thiadiazole (III), which is cyclized again with malonic acid (XI) by means of POCl3 in hot toluene to afford the previously obtained thiadiazolopyrimidine (V).
【1】 Isoda, S.; Aibara, S.; Miwa, T.; Fujiwara, H.; Yokohama, S.; Matsumoto, H. (Daiichi Pharmaceutical Co., Ltd.); Tricyclic triazolopyrimidine derivatives. AU 9052298; EP 0279298; JP 1989000086; JP 1989006264; US 4898943 . |
【2】 Narabayashi, Y. (Daiichi Pharmaceutical Co., Ltd.); Agents for treatment of gastrointestinal diseases. JP 1990138216 . |
【3】 Aihara, S. (Daiichi Pharmaceutical Co., Ltd.); Antiallergic and antiinflammatory agents. JP 1990138215 . |
【4】 Yokohama, S.; Miwa, T.; Aibara, S.; Fujiwara, H.; Matsumoto, H.; Nakayama, K.; Iwamoto, T.; Mori, M.; Moroi, R.; Tsukada, W.; Isoda, S.; Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives. Chem Pharm Bull 1992, 40, 9, 2391-8. |
【5】 Rabasseda, X.; Castaner, J.; Mealy, N.; DS-4574. Drugs Fut 1994, 19, 10, 901. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 12953 | 3-Cyclohexylpropanenitrile | C9H15N | 详情 | 详情 | |
(II) | 12954 | 1-Hydrazinecarbothioamide; Thiosemicarbazide | 79-19-6 | CH5N3S | 详情 | 详情 |
(III) | 12955 | 5-(2-Cyclohexylethyl)-1,3,4-thiadiazol-2-ylamine; 5-(2-Cyclohexylethyl)-1,3,4-thiadiazol-2-amine | C10H17N3S | 详情 | 详情 | |
(IV) | 12956 | bis(2,4,6-trichlorophenyl) malonate | C15H6Cl6O4 | 详情 | 详情 | |
(V) | 12957 | 2-(2-Cyclohexylethyl)-7-hydroxy-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | C13H17N3O2S | 详情 | 详情 | |
(VI) | 12958 | 2-(2-Cyclohexylethyl)-7-hydroxy-6-nitro-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | C13H16N4O4S | 详情 | 详情 | |
(VII) | 12959 | 7-Chloro-2-(2-cyclohexylethyl)-6-nitro-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | C13H15ClN4O3S | 详情 | 详情 | |
(VIII) | 12960 | 7-Amino-2-(2-cyclohexylethyl)-6-nitro-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | C13H17N5O3S | 详情 | 详情 | |
(IX) | 12961 | 6,7-Diamino-2-(2-cyclohexylethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | C13H19N5OS | 详情 | 详情 | |
(X) | 12962 | 3-Cyclohexylpropionic acid | 701-97-3 | C9H16O2 | 详情 | 详情 |
(XI) | 12963 | Malonic acid | 141-82-2 | C3H4O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Cyclization of the diaminoacrylate (I) with bis(2,4,6-trichlorophenyl) malonate (II) in hot toluene produced pyridone (III). This was then condensed with 2,6-dichlorobenzaldehyde (IV) in the presence of piperidine in refluxing EtOH to furnish the title bis-pyridyl derivative.
【1】 Onnis, V.; Cocco, M.T.; Congiu, C.; Synthesis and antitumor activity of 4-hydroxy-2-pyridone derivatives. Eur J Med Chem 2000, 35, 5, 545. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 47074 | ethyl (Z)-3-amino-3-(4-morpholinyl)-2-propenoate | C9H16N2O3 | 详情 | 详情 | |
(II) | 12956 | bis(2,4,6-trichlorophenyl) malonate | C15H6Cl6O4 | 详情 | 详情 | |
(III) | 47075 | ethyl 4-hydroxy-2-(4-morpholinyl)-6-oxo-1,6-dihydro-3-pyridinecarboxylate | C12H16N2O5 | 详情 | 详情 | |
(IV) | 27507 | 2,6-dichlorobenzaldehyde | 83-38-5 | C7H4Cl2O | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(IV)2-Amino-3-hydroxypyridine (I) is alkylated with N-(2-chloroethyl)piperidine (II) under phase transfer conditions to provide ether (III). Subsequent cyclization of aminopyridine (III) with bis-trichlorophenyl malonate (IV) in refluxing acetone leads to the pyridopyrimidine (V). This is finally condensed with the N-(bromomethyl)saccharin derivative (VI) to furnish the title compound.
【1】 Hermecz, I.; Kapui, Z.; Arányi, P.; Bátori, S.; Varga, M.; Dessilla, S.; Lévai, F.; Mikus, E.; Pascal, M.; Simonot, B.; Urbán Szabó, K.; Vasváriné Debreczy, L.; T. Nagy, L. (Sanofi-Synthélabo); Saccharin derivs. as orally active elastase inhibitors. WO 0144245 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 37086 | 2-amino-3-pyridinol; 2-Amino-3-hydroxypyridine | 16867-03-1 | C5H6N2O | 详情 | 详情 |
(II) | 10117 | 1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine | 1932-03-2 | C7H14ClN | 详情 | 详情 |
(III) | 62082 | 3-[2-(1-piperidinyl)ethoxy]-2-pyridinamine; 3-[2-(1-piperidinyl)ethoxy]-2-pyridinylamine | C12H19N3O | 详情 | 详情 | |
(IV) | 12956 | bis(2,4,6-trichlorophenyl) malonate | C15H6Cl6O4 | 详情 | 详情 | |
(V) | 62083 | 2-hydroxy-9-[2-(1-piperidinyl)ethoxy]-4H-pyrido[1,2-a]pyrimidin-4-one | C15H19N3O3 | 详情 | 详情 | |
(VI) | 62084 | 2-(bromomethyl)-4-isopropyl-6-methoxy-1H-1,2-benzisothiazole-1,1,3(2H)-trione | C12H14BrNO4S | 详情 | 详情 |